PRS32 Cost-Effectiveness of Omalizumab in Severe Uncontrolled Allergic Asthma Using Rct and Real-World Evidence in the Dutch Setting
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1419
https://www.valueinhealthjournal.com/article/S1098-3015(11)02981-0/fulltext
Title :
PRS32 Cost-Effectiveness of Omalizumab in Severe Uncontrolled Allergic Asthma Using Rct and Real-World Evidence in the Dutch Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02981-0&doi=10.1016/j.jval.2011.08.1419
First page :
A493
Section Title :
Respiratory-Related Disorders
Open access? :
No
Section Order :
1376